Carclo Share Discussion Threads

[garth] 16/10/2020 09:55

Any thoughts on likelihood of refinancing towards capital costs of new tooling/capacity increases?

Personally I wouldn't see it as a bad thing - other than the currently very low mkt cap compared to historic and likely future levels.

G.

[husbod] 15/10/2020 16:55

Thanks for that rivaldo but it seems odd that the company didn't blow its own trumpet on this issue in the most recent results. It did refer to the fact that it's Medical diagnostics sector was doing well but no mention of any Covid related work.

[9degrees] 12/10/2020 16:13

sure sign sometihing about to happen positively

[topnotch] 12/10/2020 15:02

And just as I post that - the price drops 1p

DOH!!!

[topnotch] 12/10/2020 13:37

*Yawn* bit slow here innit - think I'll go back to sleeeeeeeeep

[rivaldo] 07/10/2020 08:49

I was doing sone research, prompted by this morning's news about supply chain failures for testing equipment at Roche, and came across this info dating from the start of the pandemic about CAR's COVID-19 testing kit production which I'm sure hasn't been posted before:



Extracts:

"Westmoreland County company turns out vital parts for coronavirus test kits

The frontline fighters against the coronavirus in Westmoreland County most certainly include medical professionals, first responders and other health care workers treating patients.

But workers at Latrobe-based Carclo Technical Plastics are quietly supporting their efforts through the manufacturing of tiny plastic collection tubes used around the globe in coronavirus testing kits.

Carclo operates two plants in the county, one in Latrobe and a small factory in Export. About 250 employees work 12-hour daily shifts to churn out the vital parts needed for the coronavirus testing kits, as well as other needed medical supplies."

"The company last year made upwards of 1.5 billion parts for some of its products. Sales of parts for the company’s coronavirus test kits are up 40% so far this year, Stutzman said.

The company also manufactures plastic parts for respirators and other breathing treatment devices, he said.

Stutzman said the demand led him to put out a help wanted sign for his local plants in Latrobe and Export, which are seeking about 20 additional workers to operate machines and to package and inspect the products."

[wigwammer] 06/10/2020 09:03

A tick down for that? I must have got under someone's skin this morning :)

[wigwammer] 06/10/2020 08:40

If we are getting a trading update soon, the board evidently want the new man to own the narrative. Hence the departure of Antony Collins. You would only want the new guy to own the narrative if it was going to be positive (or that's my hopeful theory!)

[topnotch] 05/10/2020 16:36

May have been CINE causing the time lag - It was showing delayed prices for quite a few on my watchlist

[husbod] 05/10/2020 10:28

Time for ADVFN to catch up with the real mid price. Seem to have had a bit of a tech problem on this front this morning judging by some of my other holdings, now corrected.

[9degrees] 05/10/2020 09:19

Garth Hear hear thanks Anthony for all your efforts - onwards and upwards now

[garth] 05/10/2020 07:13

Whilst there has been considerable pain all round, Antony does, I believe, deserve the thanks of shareholders.

"The Board has decided that, given that the company has only two operating divisions, each of which has a strong management team, the role of Group CEO is no longer required. As a result, Antony Collins will step down from the Board with immediate effect. Antony joined the business as Chief Restructuring Officer in May 2019 to steer the Group through a challenging period including the exit from the Wipac business. He was appointed interim CEO from 1 October 2019 and led the Group through the negotiations with the bank and pensions trustees culminating in the successful completion of the tripartite agreement. The Board would like to thank Antony for his contribution to the business and wishes him well for the future."

G.

[topnotch] 02/10/2020 11:46

Saucepan>> We all like firm,rounded bottoms - now back to the charts...

[beeezzz] 01/10/2020 21:40

Volume increased a tad...some nice big trades..should start to move upwards over coming months..

We need to just stop worrying about a bloody virus...

[saucepan] 01/10/2020 15:46

Hi folks

I opened a starter position today, mainly on the basis of the bottom starting to round up on the chart. I gather you like the fundamentals, too :-)

[2magpies] 30/9/2020 14:28

rivaldo & wigwammer

thank you both for your informative (and generous) research/posts!

[rivaldo] 30/9/2020 11:43

Consolidating nicely at these levels.

This news item from yesterday shows CAR in a good light, and there's info on the new drug delivery device contract:



Extract:

"As part of a major project to develop and scale-up manufacture of a drug delivery device in partnership with a global medical device company, CTP has invested significantly in advanced process monitoring equipment, as well as personnel training and development, aimed at improving injection moulding process control and reducing costs of Quality Assurance (QA) and waste.

CTP has constructed a new production cell, with 14 FANUC all-electric injection moulding machines, each equipped with six-axis robots, bespoke end-of-arm tooling (EOAT) and RJG’s e-Dart process monitoring software, allied to in-mould pressure transducers.

etc"

[topnotch] 25/9/2020 13:43

Now sitting around the resistance of 22.4p

[rivaldo] 25/9/2020 09:43

Buying at 23.3p now.

[rivaldo] 24/9/2020 13:42

Nice move back up - 21.4p mid-price now. Probably due to renewed excitement at ODX and AVCT over imminent news flow.

Also worth noting that VEC have stated they now expect FDA approval for VR315 early next year.

[fillipe] 21/9/2020 10:27

Moving back up after the dip.

f

[rivaldo] 15/9/2020 09:43

Thanks Garth. Also of note in VEC's results is this - CAR were (and presumably still are) VEC's partner in the development of VR315 and the Gyrohaler platform/device from which it's delivered:

"VR315 (US) remains under review by the FDA with potential approval and launch in the second half of the year."

[garth] 15/9/2020 07:23

More from Vectura this morning - this time Interims.

This caught my eye as, perhaps, some guide to direction and speed of travel within one area of the space inhabited by Carclo:

"o 4 New CDMO contracts signed, with a further 8 signed since the period end; GBP3m-GBP5m revenue impact, expected in H2 2020"

So Vectura signing twice as many CDMOs after period end as they had done in the preceding six months...

G.

[husbod] 14/9/2020 16:31

Took advantage of the fall for a modest top up LLB. More to go here imo.